Open access
Oct 2026
Evaluation of the effectiveness of the implementation of recommendations on lipid-lowering therapy in patients with very high cardiovascular risk in medical organizations of the North-Western federal district
Cardiovascular pathology remains the leading cause of mortality in Russia, which determines the priority of correcting modifiable risk factors. According to the 2023 clinical guidelines on lipid metabolism disorders, patients at very high cardiovascular risk should be prescribed starting therapy with statin + ezetimibe...
Y. D. Mayskaya, A. V. Maslakova, S. V. Yur'yeva et al.
· Translational Medicine · 0 citations